GCL
IMGN

Glazer Capital LLC’s Immunogen Inc IMGN Stock Holding History

Glazer Capital LLC’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-268,135
Closed -$7.95M – 163
2023
Q4 		$7.95M Buy
+268,135
New +$5.34M 0.82% 22

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's IMGN Position: Q1 2024 in Review

Glazer Capital LLC sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 268,135 shares — an estimated $7.95M sold.

Glazer Capital LLC first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $7.95M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Glazer Capital LLC reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Glazer Capital LLC sold 268,135 Immunogen Inc shares in Q1 2024, an estimated $7.95M.
  • Glazer Capital LLC first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Glazer Capital LLC's Immunogen Inc position peaked at $7.95M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Glazer Capital LLC's 13F filing for Q1 2024, filed 15 May 2024.